Table 3.

Univariate analyses for PFS and OS among 127 patients who underwent curative surgery for IHCC

	Median survival (month)	P value	Median survival (month)	P value
Age
< 55 years old	10.0		18.6
≥ 55 years old	18.5	0.046	34.8	0.002
Sex
Male	15.6		28.8
Female	10.5	0.778	21.0	0.599
TMN staging
I and II	30.2		45.5
III and IV	7.7	< 0.001	15.7	< 0.001
T classification
I	15.4		23.5
II	10.4		40.2
III	16.2		24.2
IV	4.0	0.061	Not reached	0.948
Lymph node metastasis
N0	21.2		40.2
N1	6.1	< 0.001	11.5	< 0.001
Tumor differentiation
Well	51.7		Not reached
Moderate	15.6		28.8
Poor	6.7	0.003	19.4	0.027
Resection Margin
Positive	4.8		21.0
Negative	15.6	0.020	25.2	0.304
Tumor size
< 5 cm	19.8		28.8
≥ 5 cm	6.7	0.001	21.5	0.071
Hepatitis
Positive	10.4		19.0
Negative	17.6	0.005	25.2	0.079
Hypertension
Yes	11.7		21.1
No	15.6	0.856	43.0	0.074
Bile duct stone
Yes	11.7		18.6
No	15.6	0.657	30.4	0.063
Jaundice
Yes	10.2		19.4
No	15.4	0.406	25.2	0.386
Fever
Yes	10.5		21.1
No	15.4	0.737	24.8	0.920
Postoperative chemotherapy
Yes	11.7		43.0
No	15.6	0.939	23.5	0.170
CA-199
Elevated	15.4		26.0
Not elevated	11.7	0.961	28.8	0.887
CEA
Elevated	7.7		15.5
Not elevated	17.6	0.183	40.2	0.016